In vitro transfection of triple-point mutants of hypoxia-inducible factor 1 alpha into bone marrow mesenchymal stem cells

doi:10.3969/j.issn.2095-4344.2014.19.001

Abstract

Abstract:

BACKGROUND: The incidence of spinal cord injury is increasing year by year in China so that the construction of effective vascular network in local injury as soon as possible is the guarantee of metabolism and nutritional support to differentiation of all kinds of cells and healing of injury is also promoted by vascular network.
OBJECTIVE: To study the effect of triple-point mutants of hypoxia-inducible factor 1α (HIF1α) to promote angiogenesis after spinal cord injury in normoxic condition.
METHODS: Site-directed mutagenesis of 402, 564 and 803 amino acids in human HIF1α coding sequence area was completed by PCR, and the adenovirus pAdEasy-1 system was recombined with post-mutation HIF1α gene. Packaging viral and titration determination of experimental group was completed and the same was done to non mutation group and control virus group. The future experiment was continued with three virus groups and blank group (A group: including mutation HIF1α gene virus liquid; B group: including non mutation HIF1α gene virus liquid; C group: including control virus liquid; D group: blank group). Then, virus liquid was transferred into rat bone marrow mesenchymal stem cells. We observed transfection efficiency of virus by enhanced green fluorescent protein and to detect mRNA and protein expression of HIF1α gene in all transfection cells. We also detected protein expression of vascular endothelial growth factor acting as downstream angiogenesis gene of HIF1α in four groups by Western blot.
RESULTS AND CONCLUSION: Three adenoviral recombinants were successfully constructed and the packaging and identification were accomplished. The site-directed mutations of 402, 564 and 803 amino acids in coding sequence area were successful and all of them were changed to alanine. The level of HIF1α mRNA expression in both A group and B group were significantly higher than that in the C group and D group (P < 0.05). The expression levels of HIF1α and vascular endothelial growth factor proteins in A group was significantly higher than those in the other three groups (P < 0.05). These findings indicate that the HIF1α gene largely and effectively express in normoxic condition after triple-point mutation and the high-efficiency expression of vascular endothelial growth factor which is a downstream angiogenesis gene of HIF1α is promoted so that it is maybe a new therapeutic way of angiogenesis in the treatment of spinal cord injury.

中国组织工程研究杂志出版内容重点：干细胞；骨髓干细胞；造血干细胞；脂肪干细胞；肿瘤干细胞；胚胎干细胞；脐带脐血干细胞；干细胞诱导；干细胞分化；组织工程

全文链接：

Key words: stem cells, mesenchymal stem cells, spinal cord injuries, genes, vascular endothelial growth factors

CLC Number:

R394.2

Hui Chun-ying, Xiao Hong-yan, He Xin-ling, Wang Wei. In vitro transfection of triple-point mutants of hypoxia-inducible factor 1 alpha into bone marrow mesenchymal stem cells[J]. Chinese Journal of Tissue Engineering Research, 2014, 18(19): 2953-2960.

Figures/Tables 4

References

[1] Kuniyoshi Y, Koja K, Miyagi K, et al. Prevention of postoperative paraplegia during thoracoabdominal aortic surgery. Ann Thorac Surg. 2003; 76(5): 1477-1484.
[2] Dppolito G, Diabriras S, Howard GA, et al. Low oxygentension inhibits osteogenic differentiation and enhances stermness of human MIAMI cell. Bone. 2006; 39(3): 513-522.
[3] Nishimura R, Okuda K. Hypoxia is important for establishing vascularization during corpus luteum formation in cattle. J Reprod Dev. 2010; 56(1): 110-116.
[4] Giatromanolaki A, Fiska A, Pitsiava D, et al. Erythropoietin receptors in endometrial carcinoma as related to HIF1{alpha} and VEGF expression. In Vivo. 2009; 23(5): 699-703.
[5] Seregin SS, Amalfitano A. Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors. Expert Opin Biol Ther. 2009; 9(12): 1521-1531.
[6] Fiorenzo P, Mongiardi MP, Dimitri D, et al. HIF1-positive and HIF1-negative glioblastoma cells compete in vitro but cooperate in tumor growth in vivo. Int J Oncol. 2010; 36(4): 785-791.
[7] Wan C, Gilbert SR, Wang Y, et al. Activation of the hypoxia-inducible factor-1-alpha pathway accelerates. Proc Nat Acad Sci. 2008; 105(2): 686-691.
[8] Giaccia A , Siim BG , Johnson RS. HIF-1 as a target for drug development. Nat Rev Drug Discov. 2003; 2(10): 803-811.
[9] Khan TA , Sellke FW , Laham RJ. Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia. Gene Ther. 2003; 10(4): 285-291.
[10] Semenza GL. Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discov Today. 2007; 12(19-20): 853-859.
[11] Bruick RK , McKnight SL. A conserved family of prolyl- 4- hydroxylases that modify HIF. Science. 2001; 294(5545): 1337-1340.
[12] Evans CE, Humphries J, Mattock K, et al. Hypoxia and upregulation of hypoxia- inducible factor 1{alpha} stimulate venous thrombus recanalization. Arterioscler Thromb Vasc Biol. 2010; 30(12): 2443-2451.
[13] Lando D, Peet DJ, Whelan DA, et al. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science. 2002; 295(5556): 858-861.
[14] Zhang Z, Wang G, Li C, et al. Construction and characterization of a recombinant human adenovirus vector expressing bone morphogenetic protein 2. Exp Ther Med. 2013; 6(2):329-334.
[15] Liu D, Hu L, Zhang Z, et al. Construction of human BMP2-IRES-HIF1αmu adenovirus expression vector and its expression in mesenchymal stem cells. Mol Med Rep. 2013; 7(2):659-663.
[16] Emans PJ , Spaapen F , Surtel DA , et al. A novel in vivo model to study endochondral bone formation;HIF-1α activation and BMP expression. Bone。 2007; 40(2): 409-418.
[17] Lim W, Cho J, Kwon HY, et al. Hypoxia-inducible factor 1 alpha activates and is inhibited by unoccupied estrogen receptor beta. FEBS Lett. 2009; 583(8): 1314-1318.
[18] Thurston G, Suri C, Smith K, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science. 1999; 286(5449):2511-2514.
[19] Visconti RP, Richardson CD, Sato TN. Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc Natl A cad Sci USA.2002; 99(12):8219-8224.
[20] 朱国强,吴织芬,王勤涛,等. IGF-1对骨髓基质细胞分泌BMP-2和VEGF的影响[J].临床口腔医学杂志,2004, 20(4):215-217.
[21] 郜勇,杨述华,杨操,等.人血管内皮细胞生长因子重组腺病毒载体的构建、鉴定及在骨髓间充质干细胞的表达[J].中华实验外科杂志,2006,23(2):138-140.
[22] Fam NP, Verma S, Kutryk M, et al. Clinician guide to angiogenesis. Circulation. 2003; 108(21):2613-2618.
[23] Bruick RK, McKnight SL. Building better vasculature. Genes Dev. 2001; 15(19): 2497-2502.
[24] Semenza GL . HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol. 2000; 88(4):1474-1480.
[25] Rebours V, Albuquerque M, Sauvanet A, et al. Hypoxia pathways and cellular stress activate pancreatic stellate cells: development of an organotypic culture model of thick slices of normal human pancreas. PLoS One. 2013; 8(9): e76229.
[26] Cury V, Moretti AI, Assis L, et al. Low level laser therapy increases angiogenesis in a model of ischemic skin flap in rats mediated by VEGF, HIF-1α and MMP-2. J Photochem Photobiol B. 2013; 125: 164-170.
[27] Pawlus MR, Hu CJ. Enhanceosomes as integrators of hypoxia inducible factor (HIF) and other transcription factors in the hypoxic transcriptional response. Cell Signal. 2013; 25(9): 1895-1903.
[28] Ding G, Liu HD, Liang HX, et al. HIF1-regulated ATRIP expression is required for hypoxia induced ATR activation. FEBS Lett. 2013; 587(7): 930-935.
[29] Tong Y, Li QG, Xing TY, et al. HIF1 regulates WSB-1 expression to promote hypoxia-induced chemoresistance in hepatocellular carcinoma cells. FEBS Lett. 2013; 587(16): 2530-2535.
[30] Wu WJ, Zhang XK, Zheng XF, et al. SHH-dependent knockout of HIF-1 alpha accelerates the degenerative process in mouse intervertebral disc. Int J Immunopathol Pharmacol. 2013; 26(3): 601-609.
[31] Huang C, Hales BF. Effects of exposure to a DNA damaging agent on the hypoxia inducible factors in organogenesis stage mouse limbs. PLoS One. 2012; 7(12): e51937.
[32] Zimmermann SM, Würgler-Hauri CC, Wanner GA, et al. Echinomycin in the prevention of heterotopic ossification - an experimental antibiotic agent shows promising results in a murine model. Injury. 2013; 44(4):570-575.
[33] Huang SM, Chen TS, Chiu CM, et al. GDNF increases cell motility in human colon cancer through VEGF-VEGFR1 interaction. Endocr Relat Cancer. 2013; 21(1): 73-84.
[34] Steunou AL, Ducoux-Petit M, Lazar I, et al. Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development. Mol Cell Proteomics. 2013; 12(3): 736-748.
[35] Maher ER. HIF2 and endocrine neoplasia: an evolving story. Endocr Relat Cancer. 2013; 20(3): C5-7.
[36] Bensellam M, Duvillié B, Rybachuk G, et al. Glucose-induced O? consumption activates hypoxia inducible factors 1 and 2 in rat insulin-secreting pancreatic beta-cells. PLoS One. 2012; 7(1): e29807.
[37] Lange C, Caprara C, Tanimoto N, et al. Retina-specific activation of a sustained hypoxia-like response leads to severe retinal degeneration and loss of vision. Neurobiol Dis. 2011; 41(1):119-130.
[38] Pawlus MR, Wang L, Ware K, et al. Upstream stimulatory factor 2 and hypoxia-inducible factor 2α (HIF2α) cooperatively activate HIF2 target genes during hypoxia. Mol Cell Biol. 2012; 32(22): 4595-4610.
[39] Aragonés J, Elorza A, Acosta-Iborra B, et al. Myeloid hypoxia-inducible factors in inflammatory diseases. Crit Rev Immunol. 2011; 31(1): 1-13.
[40] Simon F, Bockhorn M, Praha C, et al. Deregulation of HIF1-alpha and hypoxia- regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue--influence of a modulated host stroma on the prognosis of HCC. Langenbecks Arch Surg. 2010; 395(4): 395-405.
[41] Wu XQ, Huang C, He X, et al. Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer. Cell Signal. 2013; 25(12): 2462-2468.
[42] Coudyzer P, Lemoine P, Jordan BF, et al. Hypoxia is not required for human endometrial breakdown or repair in a xenograft model of menstruation. FASEB J. 2013; 27(9): 3711-3719.
[43] Sena JA, Wang L, Hu CJ. BRG1 and BRM chromatin-remodeling complexes regulate the hypoxia response by acting as coactivators for a subset of hypoxia-inducible transcription factor target genes. Mol Cell Biol. 2013; 33(19): 3849-3863.
[44] Shen G, Li X, Jia YF, et al. Hypoxia-regulated microRNAs in human cancer. Acta Pharmacol Sin. 2013; 34(3): 336-341.
[45] Lin J, Qin X, Zhu Z, et al. FHL family members suppress vascular endothelial growth factor expression through blockade of dimerization of HIF1α and HIF1β. IUBMB Life. 2012; 64(11): 921-930.
[46] Minervini G, Masiero A, Moro S, et al. In silico investigation of PHD-3 specific HIF1-α proline 567 hydroxylation: a new player in the VHL/HIF-1α interaction pathway? FEBS Lett. 2013; 587(18):2996-3001.
[47] Green L, Cookson A, Bruce IN, et al. Identification of multiple, oxygen-stable HIF1 alpha isoforms, and augmented expression of adrenomedullin in rheumatoid arthritis. Clin Exp Rheumatol. 2013; 31(5):672-682.
[48] Elson DA , Thurston G , Huang LE , et al. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev. 2001; 15(19): 2520-2532.
[49] Li C, Liu D, Zhang Z, et al. Triple point-mutants of hypoxia-inducible factor-1α accelerate in vivo angiogenesis in bone defect regions. Cell Biochem Biophys. 2013; 67(2): 557-566.